Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2011
05/18/2011CN102066334A 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
05/18/2011CN102066333A 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors
05/18/2011CN102066330A Polymorph of 8-hydroxy-5- [(1R)-1-hydroxy-2- [[(1R) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1H)-quinolinone monohydrochloride
05/18/2011CN102066329A Crystal form of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)- quinolinone monohydrochloride
05/18/2011CN102066328A Iminopyridine derivative and use thereof
05/18/2011CN102066327A Iminopyridine derivatives and use thereof
05/18/2011CN102066326A Pyridone compound
05/18/2011CN102066325A Heteroaromatic monoamides as orexinin receptor antagonists
05/18/2011CN102066323A Novel estrogen receptor ligands
05/18/2011CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists
05/18/2011CN102066320A Aryl ketone as MRI
05/18/2011CN102066318A Process for the preparation of ezetimibe and composition containing it
05/18/2011CN102066317A Substituted aminotetralines
05/18/2011CN102066316A Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
05/18/2011CN102065902A Polymeric carrier
05/18/2011CN102065901A Drug carrier
05/18/2011CN102065896A Analgesic anti-inflammatory preparation for external application
05/18/2011CN102065886A Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
05/18/2011CN102065878A Formulation and methods for use of morinda citrifolia seed oil
05/18/2011CN102065873A Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
05/18/2011CN102065872A Probiotics to improve gut microbiota
05/18/2011CN102065869A Antiallergic marine biopolymers
05/18/2011CN102065868A Compositions for inducing immune responses specific to Globo h and SSEA3 and uses thereof in cancer treatment
05/18/2011CN102065867A Nutrition for prevention of infections
05/18/2011CN102065866A Combinations comprising methotrexate and dhodh inhibitors
05/18/2011CN102065865A Multiple myeloma treatments
05/18/2011CN102065864A Therapeutic agent for inflammatory bowel disease
05/18/2011CN102065863A Therapeutic agent for spinal canal stenosis
05/18/2011CN102065862A Treatment for neurological and mental disorders
05/18/2011CN102065861A Method for treating cognitive deficits
05/18/2011CN102065860A Method of treating anxious major depressive disorder
05/18/2011CN102065859A Substituted benzimidazoles for neurofibromatosis
05/18/2011CN102065858A Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
05/18/2011CN102065857A Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in regulating the potassium level in the blood
05/18/2011CN102065856A Combination of dronedarone with at least one diuretic, and therapeutic use thereof
05/18/2011CN102065855A Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
05/18/2011CN102065854A Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
05/18/2011CN102065853A Process for preparing and drying solid rasagiline base
05/18/2011CN102065852A Tapentadol compositions
05/18/2011CN102065851A Nanoemulsions for treating fungal, yeast and mold infections
05/18/2011CN102065849A Protective gel based on chitosan and oxidized polysaccharide
05/18/2011CN102065845A Sublingual compositions comprising (2S)-(4E)-N-methyl-5-(3-(5-isopropoxypyridin) yl)-4-penten-2-amine
05/18/2011CN102065842A Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and HPMCAS
05/18/2011CN102065840A Liposomes for drug delivery and methods for preparation thereof
05/18/2011CN102065807A Polyamine enhanced formulations for triptan compound iontophoresis
05/18/2011CN102065696A Versatile disinfectant
05/18/2011CN102065694A Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
05/18/2011CN102065687A Rasagiline for parkinson's disease modification
05/18/2011CN102062758A Impurity analysis and preparation method for clindamycin phosphate
05/18/2011CN102061321A Method for preparing glucose raw material for injection from broken rice and preparations
05/18/2011CN102061285A Application method for medicament based on NAD<+> and NADH
05/18/2011CN102061280A Bacillus subtilis SWB8 for producing diosgenin
05/18/2011CN102060942A 6-amino-6-deoxyinulin as well as preparation and application thereof
05/18/2011CN102060941A 6-deoxy alpha-amino acid derivative cyclodextrin, preparation and application thereof
05/18/2011CN102060904A Celosia argentea L. saponin compounds and application thereof
05/18/2011CN102060903A Ginsenoside Rh2 extractive and preparation method thereof
05/18/2011CN102060889A Stilbene glycoside derivative
05/18/2011CN102060888A Novel compounds
05/18/2011CN102060883A Clindamycin phosphate isomer, analysis and preparation method for same and use
05/18/2011CN102060882A Dehydrogenated clindamycin phosphate, analysis preparation method and application thereof
05/18/2011CN102060875A Novel quinazoline derivative, and preparation method and application thereof
05/18/2011CN102060869A Tindiphenyl (IV) coordination compound of benzoylformic acid-3-hydroxyl-2-naphthyl formyl hydrazone as well as preparation method and application thereof
05/18/2011CN102060864A Salicylide schiff's base and transition metal compound and preparation method thereof
05/18/2011CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/18/2011CN102060849A Dual functional radiation damage preventing and treating medicaments
05/18/2011CN102060848A Preparation and application of aromatic amine substituted pyrimidine derivatives
05/18/2011CN102060845A Fasudil crystal formation III as well as preparation method and application thereof
05/18/2011CN102060844A Fasudil crystal formation IV as well as preparation method and application thereof
05/18/2011CN102060843A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
05/18/2011CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition
05/18/2011CN102060809A Rhein derivatives and preparation and application thereof
05/18/2011CN102060808A Cinepazide acid addition salt and preparation method thereof
05/18/2011CN102060806A Cytokine inhibitors
05/18/2011CN102060802A Nitrogen and sulfur heterocyclic compound, preparation method and application thereof
05/18/2011CN102060793A Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof
05/18/2011CN102060792A 2'-aminochalcone-zole compounds, pyrazoline and cyclopropyl azole derivatives thereof and preparation method and applications of compounds
05/18/2011CN102060787A Tetramethylpyrazine ferulate crystals for suppressing platelet aggregation and thrombosis and preparation method thereof
05/18/2011CN102060786A 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof
05/18/2011CN102060772A N-(4-substituted phenyl)-1H-3-pyrazolecarboxamide cyclin dependent kinase 2 inhibitors and application thereof
05/18/2011CN102060765A Tetrahydroisoquinoline derivative, preparation method and application thereof
05/18/2011CN102060764A Tetrahydroisoquinoline derivative, preparation method and application thereof
05/18/2011CN102060759A Acylhydrazone Schiff alkaline compound and preparation method and application thereof
05/18/2011CN102060757A Acylhydrazone Schiff alkali compound and preparation method and application thereof
05/18/2011CN102060732A 5-amino-4-hydroxy-N-aryl azelamide derivatives as well as preparation methods and medical applications thereof
05/18/2011CN102060722A Arsenic compound and preparation method and use thereof
05/18/2011CN102060683A Lentinus striguellus compound as well as preparation method and application thereof
05/18/2011CN102058889A Dispersible tablet containing anticoagulants and application thereof
05/18/2011CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof
05/18/2011CN102058887A Application of P2Y4 receptor stimulant in preparing medicaments for treating Alzheimer's disease
05/18/2011CN102058886A Medical powder inhalation and application thereof
05/18/2011CN102058884A Grass carp injection vaccine synergist and preparation method thereof
05/18/2011CN102058878A Prosoma pellet tablet for generating allicin in stomach and preparation method thereof
05/18/2011CN102058876A Cervix antibacterial repair complex and preparation method thereof
05/18/2011CN102058872A Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof
05/18/2011CN102058862A Externally applied medicament for pediatric umbilical part and preparation method thereof
05/18/2011CN102058855A Traditional Chinese medicine for treating pig eczema
05/18/2011CN102058850A Application of medicine composition using oil of zedoary turmeric and borneol as raw materials
05/18/2011CN102058849A Application of Tibetan medicine composite to preparing alcohol withdrawal medicines
05/18/2011CN102058848A Application of Tibetan medicine composition to preparation of medicine for treating central neuropathic pains
1 ... 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 ... 7860